MENU
IMUX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immunic (IMUX) Ownership - Who owns Immunic?

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis... Show more

Profile

Industry
Pharmaceuticals Major
Address
1200 Avenue of the Americas
Phone
+1 332 255-9818
Employees
92
Web
https://www.imux.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
173.95M
P/E Ratio
N/A
Total Cash
N/A
Projected Growth
N/A
Total Debt
577K
Revenue
N/A
Risk (Beta)
1.16
Dividend Yield
N/A
Total Cash/Share
N/A
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
IMUX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals and oral therapies for the treatment of chronic inflammatory and autoimmune diseases

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Major
Address
1200 Avenue of the Americas
Phone
+1 332 255-9818
Employees
92
Web
https://www.imux.com